Identification of bacteria-derived HLA-bound peptides in melanoma.

Autor: Kalaora S; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Nagler A; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Nejman D; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Alon M; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Barbolin C; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Barnea E; Department of Biology, Technion - Israel Institute of Technology, Haifa, Israel., Ketelaars SLC; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Cheng K; Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA., Vervier K; Wellcome Sanger Institute, Cambridge, UK., Shental N; Department of Mathematics and Computer Science, Open University of Israel, Raanana, Israel., Bussi Y; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel., Rotkopf R; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Levy R; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Benedek G; Tissue Typing and Immunogenetics Unit, Hadassah Medical Center, Jerusalem, Israel., Trabish S; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Dadosh T; Department of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel., Levin-Zaidman S; Department of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel., Geller LT; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Wang K; Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA., Greenberg P; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Yagel G; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Peri A; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Fuks G; Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot, Israel., Bhardwaj N; The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel., Reuben A; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hermida L; Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA., Johnson SB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Galloway-Peña JR; Department of Veterinary Pathobiology, Texas A&M University, Houston, TX, USA., Shropshire WC; Department of Infectious Diseases, MD Anderson Cancer Center, Houston, TX, USA., Bernatchez C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Haymaker C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Arora R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Roitman L; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Eilam R; Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel., Weinberger A; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel., Lotan-Pompan M; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel., Lotem M; Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel., Admon A; Department of Biology, Technion - Israel Institute of Technology, Haifa, Israel., Levin Y; The de Botton Institute for Protein Profiling, The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel., Lawley TD; Wellcome Sanger Institute, Cambridge, UK., Adams DJ; Wellcome Sanger Institute, Cambridge, UK., Levesque MP; Faculty of Medicine, University of Zurich Hospital, University of Zurich, Zurich, Switzerland., Besser MJ; The Ella Lemelbaum Institute for Immuno Oncology and Melanoma, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Schachter J; The Ella Lemelbaum Institute for Immuno Oncology and Melanoma, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Golani O; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Segal E; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.; Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel., Geva-Zatorsky N; The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.; MaRS Centre, Canadian Institute for Advanced Research (CIFAR) Azrieli Global Scholar, Toronto, Ontario, Canada., Ruppin E; Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA., Kvistborg P; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Peterson SN; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Straussman R; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel., Samuels Y; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. yardena.samuels@weizmann.ac.il.

Publikováno v: Nature [Nature] 2021 Apr; Vol. 592 (7852), pp. 138-143. Date of Electronic Publication: 2021 Mar 17.

PA200-Mediated Proteasomal Protein Degradation and Regulation of Cellular Senescence.

Autor: Wen, Pei¹ (AUTHOR) 3121030151@stu.cpu.edu.cn, Sun, Yan¹ (AUTHOR) 1020222647@cpu.edu.cn, Jiang, Tian-Xia² (AUTHOR) jiangtx@bnu.edu.cn, Qiu, Xiao-Bo^1,2 (AUTHOR) jiangtx@bnu.edu.cn

Publikováno v: International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 11, p5637. 14p.

Targeting Proteasomes and the MHC Class I Antigen Presentation Machinery to Treat Cancer, Infections and Age-Related Diseases.

Autor: Rana, Priyanka S.^1,2,3 (AUTHOR) p.rana@case.edu, Ignatz-Hoover, James J.^1,2,3 (AUTHOR) james.ignatz-hoover2@uhhospitals.org, Driscoll, James J.^1,2,3 (AUTHOR) james.driscoll@uhhospitals.org

Publikováno v: Cancers. Dec2023, Vol. 15 Issue 23, p5632. 20p.

The Expression of the Immunoproteasome Subunit PSMB9 Is Related to Distinct Molecular Subtypes of Uterine Leiomyosarcoma.

Autor: Maia Falcão, Raul^1,2 (AUTHOR), Kokaraki, Georgia² (AUTHOR), De Wispelaere, Wout³ (AUTHOR), Amant, Frédéric^3,4 (AUTHOR), De Souza, Gustavo Antônio¹ (AUTHOR), de Souza, Jorge Estefano Santana^1,2 (AUTHOR), Carlson, Joseph Woodward^2,5 (AUTHOR), Petta, Tirzah Braz^1,2,5 (AUTHOR) tirzah.petta@usc.edu

Publikováno v: Cancers. Oct2022, Vol. 14 Issue 20, p5007-N.PAG. 13p.

Pan-cancer analysis of genomic and transcriptomic data reveals the prognostic relevance of human proteasome genes in different cancer types.

Autor: Larsson, Peter^1,2 (AUTHOR) peter.larsson.3@gu.se, Pettersson, Daniella^1,2 (AUTHOR), Engqvist, Hanna^1,2 (AUTHOR), Werner Rönnerman, Elisabeth^1,2,3 (AUTHOR), Forssell-Aronsson, Eva^2,4,5 (AUTHOR), Kovács, Anikó³ (AUTHOR), Karlsson, Per^1,6 (AUTHOR), Helou, Khalil^1,2 (AUTHOR), Parris, Toshima Z.^1,2 (AUTHOR)

Publikováno v: BMC Cancer. 9/19/2022, Vol. 22 Issue 1, p1-19. 19p.